Showing results (11-20 of 316) with videos related to
Sort By:
Pageof 32
Nature Reviews. Nephrology|May 29, 2009
Monoclonal antibodies for podocytopathies: rationale and clinical responsesMaddalena Marasà, Jeffrey B KoppThe American Journal of Pathology|September 12, 2018
APOL1-miR-193 Axis as a Bifunctional Regulator of the Glomerular Parietal Epithelium: Maintaining Parietal Cell Phenotype versus Promoting Podocyte DifferentiationJoseph Jessee, Jeffrey B KoppKidney International|June 23, 2022
Impact of APOL1 kidney risk variants on glomerular transcriptomesJeffrey B Kopp, Jurgen HeymannCurrent Opinion in Nephrology and Hypertension|April 17, 2003
Update in podocyte biology: putting one's best foot forwardLaura Barisoni, Jeffrey B KoppNature Clinical Practice. Nephrology|September 27, 2007
Parvovirus-B19-associated complications in renal transplant recipientsMeryl Waldman, Jeffrey B KoppKidney International. Supplement|July 17, 2003
HIV-associated nephropathy in African AmericansJeffrey B Kopp, Cheryl WinklerClinical Journal of the American Society of Nephrology : CJASN|September 19, 2007
Parvovirus B19 and the kidneyMeryl Waldman, Jeffrey B KoppClinical Kidney Journal|February 2, 2013
Viruses and collapsing glomerulopathy: a brief critical reviewPreeti Chandra, Jeffrey B KoppMicroscopy Research and Technique|May 16, 2002
Modulation of podocyte phenotype in collapsing glomerulopathiesLaura Barisoni, Jeffrey B KoppThe Journal of Clinical Investigation|April 3, 2019
c-Src is in the effector pathway linking uPAR and podocyte injuryJeffrey B Kopp, Jurgen HeymannPageof 32